bd 1047 has been researched along with enkephalin, ala(2)-mephe(4)-gly(5)- in 1 studies
Studies (bd 1047) | Trials (bd 1047) | Recent Studies (post-2010) (bd 1047) | Studies (enkephalin, ala(2)-mephe(4)-gly(5)-) | Trials (enkephalin, ala(2)-mephe(4)-gly(5)-) | Recent Studies (post-2010) (enkephalin, ala(2)-mephe(4)-gly(5)-) |
---|---|---|---|---|---|
118 | 0 | 54 | 2,727 | 1 | 374 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Burgman, M; Chien, CC; Kim, FJ; Kovalyshyn, I; Neilan, C; Pasternak, GW | 1 |
1 other study(ies) available for bd 1047 and enkephalin, ala(2)-mephe(4)-gly(5)-
Article | Year |
---|---|
Sigma 1 receptor modulation of G-protein-coupled receptor signaling: potentiation of opioid transduction independent from receptor binding.
Topics: Animals; Binding Sites; Cells, Cultured; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Ethylenediamines; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Mice; Pentazocine; Receptors, G-Protein-Coupled; Receptors, Opioid, delta; Receptors, Opioid, mu; Receptors, sigma; Sigma-1 Receptor; Signal Transduction | 2010 |